-- Marsh & McLennan (MRSH) has an average rating of Hold and mean price target of $203.62, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $173.23, Change: $-0.33, Percent Change: -0.19%
NXP Semiconductors (NXPI) said late Monday its subsidiary, NXP, along with NXP USA and NXP Funding, has redeemed $750 million in outstanding 3.875% senior notes due June 2026, in accordance with the terms of the applicable indenture.
Oluyemi Okupe, Chief Financial Officer, on April 16, 2026, sold 54,927 shares in Hims & Hers Health (HIMS) for $1,457,305. Following the Form 4 filing with the SEC, Okupe has control over a total of 277,899 Class A common shares of the company, with 270,046 shares held directly and 7,853 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1773751/000190705626000014/xslF345X05/wk-form4_1776717480.xml
Martine A Rothblatt, Director, Chairperson & CEO, on April 17, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,573,223. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,797 common shares of the company, with 40,513 shares held directly and 639,284 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000035/xslF345X05/primarydocument.xml